2023
-
David Elsley of Cardiol Therapeutics talks about their global Phase II clinical trials for the treatment of heart diseases
In this InvestorIntel interview, Chris Thompson talks to Cardiol Therapeutics Inc.’s (NASDAQ: CRDL | TSX: CRDL) CEO, President and…
-
David Regan of Sona Nanotech provides an update on its agreement with Siva Therapeutics to develop cancer treating therapies
In this InvestorIntel interview, Sona Nanotech Inc.’s (CSE: SONA | OTCQB: SNANF) CEO David Regan provides Tracy Weslosky with…
-
Bundeep Singh Rangar of Fineqia International talks about the increase in confidence for digital assets
In this InvestorIntel interview, Tracy Weslosky talks to Fineqia International Inc. (CSE: FNQ) CEO and Director Bundeep Singh…
-
John Putters and Shannon Moore on Visionstate’s WANDA Technology Partnership with Bunzl
In this InvestorIntel interview, Tracy Weslosky talks to Visionstate Corp.‘s (TSXV: VIS) CEO John Putters and President Shannon…
-
The rare earth permanent magnet dilemma is the NdPr (Neodymium-Praseodymium) supply issue
The table below was produced and sent to me by a colleague at Ginger International Trade & Investments…
